Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$2.43

Avg closing price
Price range

7 Jefferies Group Esperion Therapeutics Trades

The first Esperion Therapeutics trade was made in Q4 2022. Since then Jefferies Group bought shares one more times and sold shares on five occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Esperion Therapeutics anymore.

Avg closing price
Price range
Sold -63.5 Thousand shares Q2 2024
Avg closing price $2.35
Price range $1.84 - $3.24
New holding (+63.5 Thousand shares) Q1 2024
Avg closing price $2.43
Price range $2.02 - $3.02
Sold -65 shares Q4 2023
Avg closing price $1.30
Price range $0.73 - $3.08
Sold 99.9% shares (-112 Thousand shares) Q3 2023
Avg closing price $1.45
Price range $0.96 - $1.79
Sold 49.7% shares (-111 Thousand shares) Q2 2023
Avg closing price $1.40
Price range $1.20 - $1.76
Sold 75.4% shares (-682 Thousand shares) Q1 2023
Avg closing price $5.16
Price range $1.46 - $7.30
New holding (+905 Thousand shares) Q4 2022
Avg closing price $7.15
Price range $5.09 - $8.56

News about Esperion Therapeutics Inc. and Jefferies Group

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!